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Abstract
Background: Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease that is caused by the
expansion of a polyglutamine (polyQ) stretch within Huntingtin (htt), the protein product of the HD gene. Although
studies in vitro have suggested that the mutant htt can act in a potentially dominant negative fashion by
sequestering wild-type htt into insoluble protein aggregates, the role of the length of the normal htt polyQ stretch,
and the adjacent proline-rich region (PRR) in modulating HD mouse model pathogenesis is currently unknown.
Results: We describe the generation and characterization of a series of knock-in HD mouse models that express
versions of the mouse HD gene (Hdh) encoding N-terminal hemaglutinin (HA) or 3xFlag epitope tagged full-length
htt with different polyQ lengths (HA7Q-, 3xFlag7Q-, 3xFlag20Q-, and 3xFlag140Q-htt) and substitution of the
adjacent mouse PRR with the human PRR (3xFlag20Q- and 3xFlag140Q-htt). Using co-immunoprecipitation and
immunohistochemistry analyses, we detect no significant interaction between soluble full-length normal 7Q- htt
and mutant (140Q) htt, but we do observe N-terminal fragments of epitope-tagged normal htt in mutant htt
aggregates. When the sequences encoding normal mouse htt’s polyQ stretch and PRR are replaced with
non-pathogenic human sequence in mice also expressing 140Q-htt, aggregation foci within the striatum, and the
mean size of htt inclusions are increased, along with an increase in striatal lipofuscin and gliosis.
Conclusion: In mice, soluble full-length normal and mutant htt are predominantly monomeric. In heterozygous
knock-in HD mouse models, substituting the normal mouse polyQ and PRR with normal human sequence can
exacerbate some neuropathological phenotypes.
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Huntington’s disease (HD) is an autosomal dominant
neurodegenerative disorder that is caused by the expan-
sion of a CAG triplet repeat encoding polyQ (>36Q)
within the first exon of the HTT gene [1,2]. The length
of the expanded polyQ stretch correlates inversely with
age at onset, and moderate polyQ expansions (40-50Q)
in htt are usually associated with disease onset at mid-
dle age. Unfortunately, despite a number of therapies
targeted at individual symptoms, there is currently no
way to delay or halt progression of the disease and
death results ~10-20 years after diagnosis. Neurons in
the striatum and deeper layers of the cortex are affected
predominantly, although neuronal cell death and white
matter loss are also detected in many other areas of the
brain [3]. A neuropathological hallmark of HD is the
appearance of nuclear and cytoplasmic (neuropil) inclu-
sions of aggregated N-terminal fragments of mutant htt
[4-6]. Despite a correlation between the appearance of
htt aggregates and behavioral deficits in the majority of
HD mouse models, the role of these inclusions in the
mechanism of HD pathogenesis is still uncertain, as the
results from in vitro experiments and some HD mouse
models have suggested that large visible mutant htt
inclusions are neuroprotective [7-11]. However, such
aggregates not only have the ability to recruit toxic sol-
uble fragments or oligomers of mutant Htt, but they
can also sequester other polyQ-containing proteins, in-
cluding wild-type htt [12-15]. In vitro studies, for ex-
ample, have demonstrated that aggregates containing
both mutant and wild-type htt N-terminal fragments
are formed when mutant and wild-type truncated htt
expression constructs are co-expressed. A Q20 polypep-
tide can augment Q47 aggregation in vitro by enhancing
nucleation kinetics, and co-expression of a Q20 version
of htt exon 1 with Q93-htt exon 1 accelerated aggrega-
tion and increased toxicity in a Drosophila model [16].
Wild-type htt is an essential protein during early em-
bryogenesis, neurogenesis, and in adult neuronal
homeostasis. Loss of murine huntingtin (htt) expression
results in progressive neurodegeneration [17], increased
apoptosis [18], axonal transport deficits in neurons
[19,20], altered mitotic spindle orientation in dividing
neuronal progenitor cells [21], and hypomorphic primary
cilia [22]. Thus, potential sequestration of wild-type htt
by mutant htt could contribute to HD pathogenesis via
a dominant negative loss-of-function mechanism. In-
deed, depletion of wild-type htt in YAC transgenic HD
model mice exacerbates deficits in motor function, sur-
vival, and striatal neuronal size [23,24]. However, despite
evidence from in vitro experiments and a Drosophila
model supporting the hypothesis that truncated
N-terminal fragments of mutant Htt can sequester wild-
type htt fragments in aggregates, evidence for the
sequestration of wild-type htt by mutant htt in mouse
models is lacking.
Immediately adjacent to the htt polyQ stretch is a
proline-rich region (PRR) that is thought to have co-
evolved in vertebrates with the polyQ stretch [25]. Data
from in vitro and cell culture experiments suggest that
aggregation of mutant htt N-terminal fragments and po-
tentially sequestration of wild-type htt can also be
modulated by the adjacent PRR [26-30]. A normal htt
exon 1 construct containing the PRR can ameliorate the
toxic effects of an N-terminal 103Q construct, while a
construct expressing normal htt exon 1 without the PRR
does not [31]. The mouse htt PRR is a 32 amino acid do-
main consisting of P3,P 10,P 2, and P7 stretches inter-
rupted by short Q-rich stretches 1–3 amino acids in
length. The human PRR is slightly longer (38 amino
acids) and consists of P11 and P10 sequences interrupted
by a proline-rich 17 amino acid stretch. It is not yet
known if expression of a humanized version of normal
htt with a non-pathogenic polyQ stretch and the human
PRR can influence HD mouse model phenotypes.
To determine the extent of potential dominant-
negative interactions in vivo, and to begin to explore the
effect of expressing a non-pathogenic humanized allele
of Hdh encoding htt with a 20Q stretch and human PRR
on HD mouse model pathogenesis, we have generated a
series of knock-in HD mouse models expressing (1) the
mouse HD gene (Hdh) encoding full-length normal htt
(7Q and mouse PRR) with hemaglutinin (HA) or triple
Flag N-terminal epitope tags (HA7Q- and 3xFlag7Q-
htt), (2) a humanized normal Hdh allele encoding a
3xFlag-tagged version of htt with a 20Q stretch adjacent
to the human PRR (3xFlag20Q-htt), and (3) a humanized
Hdh allele encoding a 3xFlag-tagged version of mutant
htt with a 140Q stretch adjacent to the human PRR
(3xFlag140Q-htt). By co-immunoprecipitation, we find
that soluble full-length murine 7Q-htt does not associ-
ate stably with itself or with 140Q-htt. However, we
can detect a very low level of interaction between full-
length 3xFlag20Q-htt and 140Q-htt. In addition, we
observe a significant increase in the number of nuclear
inclusions, and in the mean size of aggregates detected
in Hdh
140Q/3xFlag20Q mice compared with Hdh
140Q/3xFlag7Q
mice. These observations, together with an increase in glio-
sis and lipofuscin accumulation in the Hdh
140Q/3xFlag20Q
brain in comparison to the Hdh
140Q/3xFlag7Q brain, sug-
gest that replacing the mouse polyQ and PRR stretches
with normal human sequence can exacerbate some as-
pects of the CAG140 HD mouse model phenotype.
Results
To insert N-terminal HA and 3xFlag epitope tags into
the Hdh locus, we assembled gene targeting constructs
by replacing an endogenous Hdh exon 1 AlwNI – XmnI
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fragment containing either the HA or 3xFlag epitope tag
inserted between htt amino acids 1 and 2. The 140Q
stretch was derived from our CAG140 targeting con-
struct [32], and contains the human proline-rich region
(PRR) that is adjacent to the polyQ stretch. The 20Q
stretch was obtained by PCR amplification of a human
wild-type allele using the same procedure employed to
isolate the CAG140 stretch, and it also contains a
human PRR (Figure 1). Germline transmission was
obtained from three independent ES cell clones
(Hdh
HA7Q/+and Hdh
3xFlag7Q/+) or two independent
clones (Hdh
3xFlag20Q/+ and Hdh
3xFlag140Q/+). All mice
have been backcrossed to the C57BL/6J strain for at least
six generations.
To establish that the addition of the HA or 3xFlag
N-terminal epitope tags did not affect htt’s essential
functions during embryonic development, the genotypes
of progeny from heterozygous intercrosses were eval-
uated for any deviation from the expected Mendelian
frequency (Table 1). Homozygous Hdh
HA7Q/HA7Q,
Hdh
3xFlag7Q/3xFlag7Q,a n dHdh
3xFlag20Q/3xFlag20Q mice were
obtained with the expected frequency, and mice hemi-
zygous for the 3xFlag epitope-tagged 7Q allele
(Hdh
3xFlag7Q/-) were obtained from crosses with Hdh
+/−
mice. Hdh
3xFlag140Q/3xFlag140Q progeny were also obtained
Figure 1 Diagram of the epitope tag-modified Hdh exon 1. The wild-type Hdh exon 1 contains a short polyQ stretch (7Q) and an adjacent
proline-rich region (mouse PRR, gray). An HA N-terminal epitope tag (green) was inserted between amino acids 1 and 2 of the Hdh exon 1
containing the wild-type mouse polyQ stretch (Hdh
HA7Q), while a 3xFlag N-terminal epitope tag (yellow) was inserted in the wild-type Hdh exon 1
(Hdh
3xFlag7Q), a chimeric mouse/human exon 1 containing a normal human polyQ stretch (Hdh
3xFlag20Q), and a chimeric mouse/human exon 1
with an expanded polyQ stretch (Hdh
3xFlag140Q). The human portion of the chimeric exon 1 is indicated in light blue and darker blue (the human
PRR), while the polyQ stretches are displayed in shades of red. The sequences of the epitope tags are indicated along with key restriction sites
used in the construction of the gene targeting vectors. A, AlwNI; X, XmnI; K, Kpn.I
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homozygous progeny trended less than that predicted
by the Mendelian frequency, (this difference, however,
did not reach significance in the χ
2 t e s t ;T a b l e1 ) ,s u g -
gesting the possibility for either increased toxicity or
that 3xFlag140Q-htt may not function as efficiently as
3xFlag7Q-htt during embryonic and early postnatal de-
velopment.AdultHdh
3xFlag7Q/-didnotexhibitanyobvious
behavioral or motor abnormalities, but future testing is
needed to determine if subtle behavioral phenotypes exist.
Gross morphology of Hdh
HA7Q/HA7Q, Hdh
3xFlag7Q/3xFlag7Q,
Hdh
3xFlag20Q/3xFlag20Q,a n dHdh
3xFlag140Q/+ brains at 6
months of age were normal (data not shown).
Confocal analysis of fresh frozen brain sections from
Hdh
3xFlag7Q/HA7Q mice at 24 months of age revealed that
HA7Q- and 3xFlag7Q-htt expression could be detected
using epitope tag-specific antibodies (Figure 2A). As
expected, there is extensive overlap in the expression of
both epitopes in the Hdh
3xFlag7Q/HA7Q brain. HA and
3xFlag epitopes are detected predominantly in the soma
and neuropil, and their expression overlaps with htt ex-
pression that is visualized with an anti-htt antibody
(MAB2166). Western analyses of HA7Q- and 3xFlag7Q-
htt expression in dissected brain regions, and in testis
from 1 month old Hdh
HA7Q/+ and Hdh
3xFlag7Q/+ mice,
respectively, revealed that the epitope-tagged versions of
htt can be detected using the appropriate anti-epitope
tag antibodies (Figure 2B).
To visualize simultaneously both normal (7Q) and
mutant (140Q) htt expression using anti-epitope tag
antibodies, fresh frozen brain sections from 12 month
old Hdh
3xFlag140Q/HA7Q mice were analyzed by confocal
microscopy following incubation with FLAG M2 and
HA antibodies to detect 3xFlag140Q- and HA7Q-htt, re-
spectively. Htt inclusions were visualized with the
aggregation-specific mEM48 (MAB5374) antibody, and
nuclei were stained with the fluorescent DNA dye, To-
Pro-3 (Figure 3A). In cortex, diffuse and bright punctate
neuropil staining , in addition to nuclear staining in a
portion of the cells, was observed with the FLAG anti-
body. In contrast, diffuse HA7Q-htt staining was
observed in the neuropil, and in nuclei that also stained
with the 3xFlag epitope. HA staining was also detected
in several punctae that co-stained with the Flag anti-
body. Flag staining was present in the neuropil, in a sub-
set of nuclei (Figure 3A), and was detected in neuropil,
perinuclear, and nuclear punctae that co-stained with
the mEM48 antibody (Figure 3B). Thus, the 3xFlag epi-
tope can be detected in presumptive soluble mutant htt,
nuclear inclusions, and neuropil inclusions, while the
HA epitope can be detected predominantly in the
neuropil, in a subset of nuclei that also stained with mu-
tant htt, and in some htt inclusions.
Soluble full-length 7Q-htt does not interact with itself or
with full-length 140Q-htt
Prior in vitro observations, cell culture studies, and
experiments in Drosophila have demonstrated that mu-
tant htt can sequester normal htt in protein aggregates,
but recent analyses of human postmortem brain extracts
and protein extracts derived from HD mouse models
using blue native polyacrylamide gel eletrophoresis
(BNP) have shown that full-length normal and mutant
htt are predominantly monomeric [33]. To confirm that
epitope-tagged normal htt exists predominantly as a
monomer in our mouse models, we immunoprecipitated
3xFlag7Q-htt from cerebellar and striatal protein
extracts prepared from 1 month-old Hdh
3xFlag7Q/HA7Q
mice, and forebrain extracts prepared from 12 month-
old Hdh
3xFlag7Q/HA7Q mice (Figure 4). Flag antibody-
bound and non-bound fractions were then analyzed by
western blotting using FLAG and HA antibodies. In
both 1 month and 12 month-old mice, Flag3x7Q-htt
was efficiently immunoprecipitated. HA7Q-htt, in con-
trast, was detected only the antibody non-bound fractions.
Thus, in both young and older mice, epitope-tagged htt
exists primarily as a monomer in our protein extracts
using our co-immunoprecipitation conditions.
Table 1 Chi square analyses of genotypes produced from
heterozygous and hemizygous crosses
Genotype # Observed (# Expected) χ
2 (P)
Cross: Hdh
3xFlag7Q/+ X Hdh
3xFlag7Q/+
+/+ 16 (23) 1.69 (0.429)
3xFlag7Q/+ 51 (46)
3xFlag7Q/3xFlag7Q 26 (23)
Cross: Hdh
HA7Q/+ X Hdh
HA7Q/+
+/+ 16 (20) 1.01 (0.603)
HA7Q/+ 39 (40)
HA7Q/HA7Q 25 (20)
Cross: Hdh
3xFlag20Q/+ X Hdh
3xFlag20Q/+
+/+ 6 (6) 0.0697 (0.966)
3xFlag20Q/+ 12 (12)
3xFlag20Q/3xFlag20Q 5 (6)
Cross: Hdh
3xFlag7Q/+ X Hdh
+/-
+/+ 2 (4) 1.15 (0.765)
3xFlag7Q/+ 6 (4)
3xFlag7Q/- 4 (4)
+/- 5 (4)
Cross: Hdh
3xFlag140Q/+ X Hdh
3xFlag140Q/+
+/+ 9 (10) 2.03 (0.362)
3xFlag140Q/+ 24 (20)
3xFlag140Q/3xFlag140Q 5 (10)
The observed and expected numbers of the homozygous and hemizygous
progeny are in bold.
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extracts from 6 month-old Hdh
140Q/3xFlag7Q mice to de-
termine if soluble full-length mutant htt can interact
with normal htt. Following immunoprecipitation of
3xFlag7Q-htt with anti-FLAG agarose beads, antibody-
bound and non-bound fractions were analyzed by west-
ern blotting using Flag and expanded polyQ (1C2)
antibodies (Figure 5A). While 3xFlag7Q-htt was en-
riched in the antibody bound fractions, 140Q-htt was
detected only in the antibody non-bound fraction. We
interpret this result to suggest that little, if any, stable
interaction between normal and mutant htt occurs in
the 6 month-old Hdh
140Q/3xFlag7Q brain. To determine if
an association between normal and mutant htt can be
Figure 2 Expression of HA7Q-htt and 3xFlag7Q-htt in selected brain regions. (A) Confocal microscopy of HA epitope (HA), 3xFlag7Q
epitope (FLAG), and htt (Htt) expression in the 24 month-old Hdh
3xFlag7Q/HA7Q striatum and cortex. Nuclei were visualized with the DNA dye
To-Pro-3 (blue). Arrows indicate examples of where co-localization of the HA and 3xFlag epitopes, or of the epitopes with htt occurs.
Scale bar = 25 μm. (B) Western blot analysis of HA7Q-htt (left panel) and 3xFlag7Q-htt (right panel) in 50 μg total protein isolated from Hdh
HA7Q/+
and Hdh
3xFlag7Q/+ testis and various brain regions (brain stem: br stem, cerebellum: cb, thalamus: thal, striatum: str, and cortex: ctx). The antibodies
used (monoclonal antibodies HA.11 and MAb FLAG M2) and the position of a 200 kD protein marker are indicated.
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140Q/3xFlag7Q or Hdh
3xFlag140Q/HA7Q
mice, co-immunoprecipitation experiments were per-
formed using whole brain extracts prepared from 13
month-old Hdh
3xFlag140Q/HA7Q, and 27 month-old
Hdh
140Q/3xFlag7Q mice. Cytoplasmic extract from the
Hdh
3xFlag140Q/HA7Q and Hdh
140Q/3xFlag7Q brains was
immunoprecipitated with anti-expanded polyQ (1C2)
or Flag antibodies, using Protein G-agarose beads, and
western blots of antibody-bound and non-bound frac-
tions were probed with 1C2 (recognizing 3xFlag140Q-htt
and 140Q-htt), and MAB2166 (recognizing both normal
and mutant htt) antibodies (Figure 5B, C). HA7Q-htt
did not co-immunoprecipitate with 3xFlag140Q-htt, and
similarly 140Q-htt did not co-immunoprecipitate with
3xFlag7Q-htt, suggesting that in older mice, a stable
interaction between full-length 7Q-htt and 140Q-htt
does not occur. To control for non-specific association
of htt with the Protein G agarose-beads, whole extract
was incubated with Protein G-agarose beads in the ab-
sence of 1C2 or Flag antibodies, and the antibody-bound
and non-bound fractions were probed with 1C2 and
2166 antibodies (Figure 5B, C). Htt was not detected in
the control bound fractions, indicating that little, if any,
non-specific binding of htt to the agarose beads
occurred.
A low level of interaction between full-length 20Q-htt and
140Q-htt can be detected by co-immunoprecipitation
To determine if normal htt with a 20Q stretch and
human PRR can interact with full-length mutant htt, we
performed FLAG immunoprecipitations with Protein-G
agarose beads using whole brain extracts prepared from
16 month-old Hdh
140Q/3xFlag20Q mice, and probed the
Flag antibody-bound and non-bound fractions with 1C2
and 2166 antibodies (Figure 5C). A very low level of
interaction between 140Q- and 3xFlag20Q-htt was
detected in the whole brain protein extracts. We esti-
mate that under our co-immunoprecipitation conditions,
< 2.5% of soluble full-length mutant htt was associated
with 3xFlag20Q-htt (see Methods).
Sequestration of normal htt in Hdh
140Q/3xFlag7Q and
Hdh
140Q/3xFlag20Q striatal inclusions
To explore the effect of expressing a version of htt
with a normal human polyQ stretch and human PRR
on HD mouse model phenotypes, we first compared
Figure 3 Expression of 3xFlag140Q-htt and HA7Q-htt in 12 month-old Hdh
3xFlag140Q/HA7Q cortex and striatum. (A) Confocal microscopy of
fresh frozen brain sections containing the striatum and piriform cortex were immunostained with rabbit anti-Flag (green) and mouse anti-HA
antibodies (red), while nuclei were visualized with the DNA dye To-Pro-3 (blue). In both the cortex and striatum, the Flag antibody stains a
fraction of the nuclei, punctae, and to a lesser extent, the neuropil. HA staining is found diffusely in both the neuropil and in some nuclei. A few
punctae co-stain with both Flag and HA antibodies in the cortex and striatum (open arrowheads), and filled arrowheads mark examples of nuclei
co-staining with both antibodies. (B) In striatal sections co-immunostained with both Flag and an aggregation-specific antibody (mEM48;
MAB5374), the majority of htt inclusions in the neuropil are stained with both antibodies (open arrowheads). Scale bar = 25 μm.
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Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q mice at 2 months,
4 months, 6 months, and 24 months of age (n=4 of each
genotype) (Figure 6). For both genotypes, htt inclusions
were first detected using the MW8 aggregation-specific
antibody at 6 months of age, and at this age, the number
of nuclear inclusions was greater than that of the neuro-
pil aggregates in both genotypes. By 24 months of age,
there was a widespread increase in the number of stri-
atal nuclear and neuropil aggregates in both genotypes
(Figure 6). Interestingly, the total number of inclusions in
the 6 month-old Hdh
140Q/3xFlag20Q striatum was signifi-
cantly greater than that found in the Hdh
140Q/3xFlag7Q
striatum (Figure 6B). This difference was due entirely to
an increase in the number of nuclear inclusions in the
Hdh
140Q/3xFlag20Q brain, as there was no significant differ-
ence in the number of neuropil aggregates between the
two genotypes (Figure 6C).
Although the number of nuclear and neuropil aggre-
gates was not significantly different in the 24 month-old
Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q brains, the size of
the inclusions appeared larger in the Hdh
140Q/3xFlag20Q
striatum (Figure 6A, 7A). To quantify the size of the
aggregates, we determined the average MW8
+ pixel area
per aggregate in confocal images by dividing the total
MW8
+ pixel area by the number of aggregates (Figure 7B).
At 6 months of age, no significant difference in the mean
size of aggregates was observed in the Hdh
140Q/3xFlag7Q
and Hdh
140Q/3xFlag20Q striatum. At 24 months of age, how-
ever, we observed a significant increase in the mean aggre-
gate size in the Hdh
140Q/3xFlag20Q striatum in comparison
to the Hdh
140Q/3xFlag7Q striatum.
To compare the extent of the co-localization of
3xFlag20Q-htt with 140Q-htt vs. 3xFlag7Q-htt with
140Q-htt in aggregates, we quantified the percentage of htt
aggregates that co-stained with both Flag and MW8 anti-
bodies in the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q stri-
atum using confocal microscopy (Figure 8A). At 6 months
of age, we observed no significant difference in the per-
centage of htt aggregates that contained the 3xFLAG epi-
tope in the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q
striatum(Figure8B).At24monthsofage,therewasatrend
towardsincreasedco-localizationofepitope-taggednormal
htt with mutant htt in the Hdh
140Q/3xFlag20Q brain in com-
parison to the Hdh
140Q/3xFlag7Q brain (P=0.06) (Figure 8B).
This result suggests that 3xFlag20Q-htt may be recruited
into inclusions more efficiently than 3xFlag7Q-htt, and
this could contribute to the increased average size of ag-
gregates we observed in the Hdh
140Q/3xFlag20Q striatum.
To confirm that normal htt was sequestered in mutant
htt inclusions, we first performed cellulose acetate filter
trap assays [34] with the initial 800xg pellet fraction from
24 month-old Hdh
140Q/3xFlag7Q whole brain extracts (con-
taining crude nuclei and insoluble htt aggregates)
(Figure 9A). 1C2, mEM48, and Flag-positive htt inclusions
trapped on the cellulose acetate were detected by western
blotting, while an underlying PVDF membrane was posi-
tive for SDS-soluble 140Q- and 3xFlag7Q-htt species, but
negative for mEM48-positive aggregates.
In both full-length and truncated mutant htt HD mouse
models, the predominant species of mutant htt found in
macroscopic inclusions consists of N-terminal fragments
[35-37]. To determine if epitope-tagged N-terminal frag-
ments of normal htt were present in the inclusions, we
extracted the SDS-insoluble 800xg pellet fraction obtained
from 24 month old Hdh
140Q/3xFlag7Q, Hdh
140Q/3xFlag20Q,
and Hdh
3xFlag140Q/HA7Q brains with formic acid to
solubilize the htt aggregates [38-40], and performed west-
ern blotting using Flag and 1C2 antibodies to visualize
full-length and N-terminal fragments of normal and mu-
tant htt (Figure 9B). In the formic acid-solubilized SDS-
insoluble nuclear fractions, we could detect 140Q- and
3xFlag140Q-htt fragments with the 1C2 antibody that
ranged in size from ~100 kD to ~250 kD, and app-
arently full-length mutant htt. The Flag antibody
detected an increased level of 3xFlag20Q-htt fragments
in comparison to 3xFlag7Q-htt fragments. We interpret
these data to suggest that sequestration of normal htt
N-terminal fragments into inclusions does occur in het-
erozygous knock-in HD mouse models, and is enhanced
by expression of a humanized version of the normal
Hdh allele.
Figure 4 Full length 3xFlag7Q-htt and HA7Q-htt do not
co-immunoprecipitate. 0.5 mg cytoplasmic extract prepared from
thecerebellum(Cb)andstriatum(Str)ofa1month-oldHdh
3xFlag7Q/HA7Q
mouse(A) andfromtheforebrainof a12month-oldHdh
3xFlag7Q/HA7Q
mouse(B) was immunoprecipitatedwithanti-FLAGM2agarosebeads.
Theantibody non-boundsample(NB) represents10%ofthetotalNB
fraction,andtheantibody-bound sample(B) represents33%of the
totalB sample.Proteinwas resolvedon5%SDS-PAGE,transferredto
PVDFmembranes,andprobedwitheitherFLAGM2orHA.11
antibodies. Inboththe1month-and12month-oldmice,HA7Q-htt
wasfoundentirelyintheNBfractionsuggestingthatthereis nostable
interactionbetweenfull-lengthsoluble7Q-htt.Thepositionsofhtt,
anda250 kDproteinsizestandardare indicated.
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occurs when mouse htt’s 7Q stretch and PRR are replaced
by a 20Q stretch and the human PRR in Hdh
140Q/3xFlag20Q
mice
The large neuropil and nuclear inclusions that we visua-
lized by standard immunohistochemical methods using
the MW8 and mEM48 (MAB5374) antibodies may not
represent all the sites where aggregates are forming. To
visualize these sites, treatment of tissue sections with
formic acid to expose the expanded polyQ epitope
within the htt aggregates prior to antibody staining is
required [41]. Using this method, small neuropil aggre-
gates and aggregation foci located in striatal neuronal
processes resembling chains of immuno-positive punctae
were observed [41]. Such 1C2
+ punctae were detected
in both Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q striata
Figure 5 A low level of interaction between full-length 140Q-htt and 3xFlag20Q-htt but not 3xFlag 7Q-htt can be detected by
co-immunoprecipitation. (A) 700 μg of cytoplasmic protein prepared from the striatum (Str) and cerebellum (Cb) of a 6 month-old Hdh
140Q/3xFlag7Q
mouse was immunoprecipitated with anti-Flag agarose beads, and separated into antibody non-bound (NB) and antibody-bound (B) fractions.
Duplicate samples (Input Str represents 56 μg protein, while each NB sample represents 8% of the fraction, and each B sample represents 10% of
the fraction for the anti-FLAG blot, and 40% of the fraction for the 1C2 blot) were fractionated on 5% SDS-PAGE and analyzed by western
blotting with the indicated antibodies. 140Q-htt was not detected in the B-fractions, suggesting that a stable interaction between 140Q-htt and
3xFlag7Q-htt was below detection limits. (B) 500 μg whole brain cytoplasmic extract from a 13 month-old Hdh
3xFlag140Q/HA7Q mouse was
immunoprecipitated with anti-FLAG or 1C2 antibodies using Protein G-agarose beads, and the NB- and B-fractions were analyzed by western
blotting using 1C2 and 2166 antibodies. (C) 500 μg whole brain cytoplasmic extract from 27 month-old Hdh
140Q/3xFlag7Q and 16 month-old
Hdh
140Q/3xFlag20Q mice was immunoprecipitated with anti-FLAG antibody and Protein-G agarose beads, and the NB- and B-fractions were analyzed
by western blotting using 1C2 and 2166 antibodies. Shorter and longer exposures of the western blots are shown in the top two panels of (B,C).
As a negative control for non-specific binding of htt to the agarose beads, antibody was omitted from the mixture of protein extract and Protein
G-agarose beads (No Ab) in (B,C). An arrowhead marks the position of 140Q-htt co-immunoprecipitating with 3xFlag20Q-htt, while an asterisk
indicates 3xFlag20Q-htt that is detected inefficiently by the 1C2 antibody when it is present in large amounts (C). The position of a 250 kD
protein standard is indicated on the left.
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pixel area of the 1C2
+ punctae, as they were difficult to
resolve clearly. We observed a significant increase in
1C2 staining following formic acid treatment in the
Hdh
140Q/3xFlag20Q striatum in comparison to the
Hdh
140Q/3xFlag7Q striatum at both 6 months and 24
months of age (Figure 10B). Unfortunately, we could not
detect co-localization of the 3xFlag epitope with the
expanded polyQ epitope, as we were unable to recover
FLAG immunoreactivity following formic acid treatment
(data not shown). Nevertheless, our observations suggest
that increasing the length of the normal htt polyQ
stretch and/or replacing the mouse PRR with the human
PRR can enhance the formation of small cytoplasmic htt
aggregates.
Increased astrocytosis and lipofuscin accumulation is
observed in Hdh
140Q/3xFlag20Q mice compared to
Hdh
140Q/3xFlag7Q mice
In HD mouse models and in the HD brain, reactive
astrocytosis occurs as a consequence of mutant htt ex-
pression [42-44]. To determine if astrocytosis in
Hdh
140Q/3xFlag20Q mice is altered in comparison to that
observed in Hdh
140Q/3xFlag7Q mice, we examined glial fi-
brillary acidic protein (GFAP) expression by immunohis-
tochemistry in the striatum of 24 month-old wild-type,
Figure 6 Time course and quantification of htt inclusions in the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q striatum. (A) Representative
confocal images of the striatum at 2 months, 4 months, 6 months, and 24 months of age. An image from a 24 month-old wild-type (WT) control
is also shown for comparison. 3xFlag7Q- and 3xFlag20Q-htt were detected with the FLAG M2 antibody (green), while htt inclusions were
visualized using the MW8 antibody (red). Nuclei were visualized with To-Pro-3 (blue). White arrows indicate inclusions co-staining with the Flag
antibody. Scale bar = 25 μm. (B) Quantification of total htt aggregate number/imaging field. (C) Quantification of total htt aggregate number (T),
nuclear aggregate number (N) and neuropil aggregate number per imaging field at 6 months and 24 months of age (n=3 mice for each age and
genotype). A significant difference in aggregate number between the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q striatum was observed in the nuclear
compartment at 6 months of age. Error bars=SEM, *P<0.05.
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140Q/3xFlag7Q, Hdh
140Q/3xFlag20Q,a n dHdh
140Q/3xFlag140Q
mice (Figure 11A). As expected, GFAP immunostaining
was relatively low in the wild type striatum (measured as
total pixel area of GFAP signal/field), likely reflecting
the basal expression of GFAP in resident astrocytes. In
all three HD mouse models, however, GFAP immunos-
taining was significantly higher in the mutant striatum
in comparison to the wild type striatum (Figure 11B).
A significant increase in astrocytosis was observed in the
Hdh
140Q/3xFlag7Q striatum compared to wild-type stri-
atum, and in the Hdh
140Q/3xFlag20Q striatum compared to
the Hdh
140Q/3xFlag7Q striatum.
In addition to the gliosis observed in HD, elevated
levels of lipofuscin are detected in HD mouse models,
and in the HD brain [43,45,46]. Lipofuscin is an auto-
fluorescent aging pigment that accumulates over time
Figure 7 The mean size of htt inclusions in the Hdh
140Q/3xFlag20Q striatum is significantly larger than that in the Hdh
140Q/3xFlag7Q
striatum at 2 years of age. (A) Confocal images of the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q striatum at 24 months of age. Htt inclusions were
detected with the MW8 antibody (red) and nuclei with To-Pro-3 (blue). Scale bar = 25 μm. (B) Quantification of the average size (total MW8
+
pixels/inclusion number per imaging field) of htt inclusions in the Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q striatum at 6 months and 24 months of
age (n=3 for each age and genotype, mean ± SEM plotted). **P<0.01.
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primarily of cross-linked lipid, and is generated by the
autophagic catabolism of membrane and organelles
[47]. In HD, oxidative stress can result in the increased
accumulation of perinuclear lipofuscin deposits in neu-
rons. We assessed lipofuscin accumulation in the stri-
atum of 24 month-old wild-type, Hdh
140Q/3xFlag7Q, and
Hdh
140Q/3xFlag20Q,t oHdh
140Q/3xFlag140Q mice, and found
that there was a trend towards increased lipofuscin accumu-
lation in the striatum: wild-type<Hdh
140Q/3xFlag7Q<
Hdh
140Q/3xFlag20Q<Hdh
140Q/3xFlag140Q.B o t hHdh
140Q/3xFlag20Q
and Hdh
140Q/3xFlag140Q mice had significantly more
striatal lipofuscin in comparison to wild-type mice, but
there was no significant difference in the amount of
striatal lipofuscin observed between wild-type and
Hdh
140Q/3xFlag7Q mice (P=0.056), between Hdh
140Q/3xFlag20
and Hdh
140Q/3xFlag7Q mice (P=0.6), or between
Hdh
3xFlag140Q/140Q and Hdh
140Q/3xFlag20Q mice (P=0.46)
(Figure 11C, D).
Discussion
Our results are compatible with the hypothesis that the
expanded polyQ stretch within mutant htt can interact
in vivo with non-pathogenic lengths of polyQ in wild-
Figure 8 Co-localization of 3xFlag7Q- and 3xFlag20Q-htt with 140Q-htt in htt inclusions. (A) Confocal images of the Hdh
140Q/3xFlag7Q and
Hdh
140Q/3xFlag20Q striatum at 24 months of age. Htt inclusions were detected with MW8 (red), while a Flag antibody was used to detect htt with
the normal polyQ stretch. White arrows indicate examples of inclusions that contain the 3xFlag epitope (yellow). Scale bar = 25 μm. (B) The %
co-localization between the Flag epitope and htt inclusions (Flag
+ MW8
+ inclusions/MW8
+ inclusions per microscopic field) (n=4 mice of each
genotype, mean ± SEM plotted ). Although there appeared to be a trend for slightly increased co-localization of 3xFlag20Q-htt with the MW8
+
inclusions at 24 months of age, a significant difference between the two genotypes was not found (P=0.06).
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ing a polyQ stretch. Sequestration between expanded
and normal-length polyQ stretches occurs predomin-
antly between proteolytically processed N-terminal frag-
ments of htt, as we detect little interaction between
soluble full-length 140Q-htt and 3xFlag20Q-htt. More-
over, this level of interaction is so low (<2.5% of mutant
htt is associated with normal htt) that it is unlikely that
sequestration is contributing to potential loss-of-
function phenotypes in vivo by reducing the steady-state
levels of normal htt. Our co-immunoprecipitation data
also suggest that full-length wild-type mouse htt (7Q-
htt) does not interact stably with itself, and supports
prior work suggesting that htt is predominantly a mono-
meric protein in vivo [33,48,49], with the caveat that our
conditions of co-immunoprecipitation select for stable
interactions, and a weak or transient association between
htt monomers would likely escape detection.
The number of htt inclusions detected in older mice
using the aggregation-specific MW8 antibody was not
altered significantly when the polyQ stretch in normal
htt was increased from 7Q to 20Q, and the mouse PRR
was substituted with a human PRR, despite a significant
increase in the number of Hdh
140Q/3xFlag20Q nuclear
inclusions that was observed at 6 months of age. How-
ever, the mean size of htt aggregates was significantly
larger in the Hdh
140Q/3xFlag20Q striatum in comparison
to Hdh
140Q/3xFlag7Q striatum at 12 and 24 months of
age. A potential explanation for these observations is
that an interaction between N-terminal fragments of
Figure 9 Detection of 3xFlag7Q- and 3xFlag20Q-htt in the SDS-insoluble nuclear fractions from Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q
brains. (A) Aliquots of the crude nuclear fraction obtained from the whole brain of a 24 month-old Hdh
140Q/3xFlag7Q mouse were heated in the
presence of SDS and analyzed by cellulose filter trap assay and western blotting. SDS-resistant htt inclusions trapped on the cellulose acetate
membrane were detected with 1C2 and MAB5374 antibodies, while sequestered 3xFlag7Q-htt was detected with the FLAG M2 antibody.
SDS-soluble 140Q-htt and 3xFlag7Q-htt species were detected on the PVDF membrane using 1C2 and FLAG antibodies. (B) Crude nuclear
fractions were obtained 24 month-old Hdh
140Q/3xFlag7Q (140Q/3xF7Q), Hdh
140Q/3xFlag20Q (140Q/3xF20Q), and Hdh
3xFlag140Q/HA7Q (3xF140Q/HA7Q)
brains, boiled in the presence of SDS, sonicated, and the remaining SDS-insoluble material was extracted with formic acid. The formic
acid-solubilized fractions were analyzed by western blotting using Flag (FLAG M2, left panel), and 1C2 antibodies (right panel). 3xFlag epitope
immunoreactivity in the Hdh
140Q/3xFlag20Q nuclear fraction is increased in comparison to the Hdh
140Q/3xFlag7Q fraction. The sizes of protein standards
(in kD) are indicated.
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kinetics, facilitating small htt inclusion formation in
Hdh
140Q/3xFlag20Q mice. Larger numbers of small htt
inclusions could then increase the probability that they
can coalesce into larger inclusions that are recognized
by the MW8 antibody in the Hdh
140Q/3xFlag20Q brain.
Our data obtained using formic acid to both expose
the expanded polyQ epitope in tissue sections and to
solubilize nuclear-associated htt aggregates, provide evi-
dence supporting this scenario. Small cytoplasmic htt
aggregates were increased at both 6 months and 24
months of age in the Hdh
140Q/3xFlag20Q striatum in
Figure 10 Formic acid treatment reveals an increase in small 1C2
+ inclusions in the Hdh
140Q/3xFlag20Q striatum in comparison to
Hdh
140Q/3xFlag7Q striatum. (A) Images of the striatum from 6 month-old and 2 year-old Hdh
140Q/3xFlag7Q and Hdh
140Q/3xFlag20Q mice probed with
1C2 antibody (red) following formic acid treatment. Nuclei were visualized with To-Pro-3. Examples of “aggregate chains” are indicated with white
arrows. Scale bar = 25 μm. (B) Quantification of the total 1C2
+ pixel area per microscopic field in the striatum of Hdh
140Q/3xFlag7Q and
Hdh
140Q/3xFlag20Q mice at 6 months and 24 months of age (n=3 mice for each age and genotype, mean ± SEM). *P<0.05.
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140Q/3xFlag7Q striatum, and higher
levels of 3xFlag20Q-htt N-terminal fragments were
detected in nuclear-associated formic acid-solubilized
aggregates in comparison to 3xFlag7Q-htt fragments in
age-matched controls. These data are compatible with
prior in vitro observations suggesting that normal length
polyQ polypeptides enhance the nucleation kinetics of
an expanded polyQ polypeptide in a process that is both
concentration- and polyQ length-dependent [16].
An alternative to the polyQ-dependent enhanced nu-
cleation hypothesis that cannot be excluded by our data
is that substitution of the mouse PRR with the human
PRR in 3xFlag20Q-htt also contributed to the pheno-
typic differences between the Hdh
140Q/3xFlag7Q and
Figure 11 Gliosis and lipofuscin accumulation in Hdh
140Q/3xFlag20Q and Hdh
140Q/3xFlag7Q mice. (A) Images of the striatum of 2 year-old wild
type (+/+), Hdh
140Q/3xFlag7Q, Hdh
140Q/3xFlag20Q, and Hdh
140Q/3xFlag140Q mice probed with antibodies against GFAP (green) and htt inclusions (MW8,
red). Nuclei were visualized with To-Pro-3 (blue). (B) The mean total pixel area of GFAP staining per microscopic field of the ventral striatum was
plotted for each genotype (n=3 mice for each genotype). (C) Images of lipofuscin autofluorescence (yellow) in the striatum of 2 year-old wild
type (+/+), Hdh
140Q/3xFlag7Q, Hdh
140Q/3xFlag20Q, and Hdh
140Q/3xFlag140Q mice. Nuclei were stained with To-Pro-3. (D) The mean total pixel area of
lipofuscin autofluorescence was plotted for each genotype (n=3 mice for each genotype, mean ± SEM plotted). *P<0.05, **P<0.01 in B,D. Scale
bar = 25 μmi nA,C.
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140Q/3xFlag20Q mice that we observed. Mammalian
cell culture experiments with truncated N-terminal wild-
type and mutant htt expression constructs have provided
data suggesting that htt amino acids located C-terminal
to the polyQ stretch can influence co-aggregation of mu-
tant and wild-type htt fragments [30]. Moreover, data
from both yeast and mammalian cell culture studies sug-
gest that the htt PRR may be involved in the formation
of the aggresome [28,29]. A future test of this hypothesis
would require the generation of Hdh alleles encoding
full-length 7Q-htt with the human PRR and 20Q-htt
with the mouse PRR.
The htt aggregation phenotype we detect in the
Hdh
140Q/3xFlag20Q mice was accompanied by enhanced
gliosis and lipofuscin accumulation. In HD, however, it
is unclear whether or not increasing the length of the
CAG repeat in the normal HTT allele can affect patho-
genesis. In a study combining data from 533 individuals
from the Huntington’s Disease Modifiers of Age at
Onset in Pairs of Siblings (HD-MAPS) study and 221
individuals from the Huntington Disease Center with
Walls (NEHD) study, evidence was found supporting a
genetic interaction between the normal and mutant
HTT alleles – age at onset decreases when the normal
CAG repeat length increases from 6–17 to 18–19
repeats, and increases when the CAG repeats range from
20–34 [50]. This effect on age-at-onset from the normal
allele is small, however (1–2 year difference in age-at-
onset), and may reflect the difficulty associated with de-
termining a precise time for symptomatic onset. In a
more recent study involving 921 subjects, increasing the
size of the normal htt polyQ stretch correlated with a
lower age-at-onset and increased clinical severity if the
mutant htt polyQ stretch length was between 36Q and
44Q, while the opposite effect was observed if the mu-
tant Htt polyQ stretch was >44Q [51]. However, two
more recent studies could find no evidence supporting
the hypothesis that the size of the polyQ stretch in the
normal HTT allele influences age-at-onset [52,53]. Our
data suggest that some neuropathological phenotypes are
enhanced by expressing 3xFlag20Q-htt in the CAG140
mouse model. However, additional studies will be needed
to determine if the age-at-onset, severity, and progression
of all knock-in HD mouse model phenotypes are simi-
larly affected. In addition, we will need to examine if sub-
stitution of the mouse PRR with the human PRR is also
contributing to the differences observed between the
Hdh
140Q/3xFlag20Q and Hdh
140Q/3xFlag7Q mice.
The generation of Hdh knock-in alleles expressing
N-terminal epitope-tagged 7Q-, 20Q-, and 140Q-htt pro-
vide additional tools for understanding normal and mu-
tant htt function in the mouse. However, we caution that
the incorporation of the N-terminal epitope tag may per-
turb htt function. In yeast, a Flag epitope tag at the N- or
C-terminus of constructs expressing truncated N-terminal
fragments of mutant htt enhanced cytotoxicity [54]. Simi-
larly, our 3xFlag or HA tags may influence the structure
and function of both normal and mutant htt in our
knock-in mouse models. Nevertheless, we obtained the
predicted numbers of Hdh
3xFlag7Q/3xFlag7Q homozygotes,
and Hdh
3xFlag7Q/- hemizygotes, suggesting that normal
htt’s essential developmental functions were not affected
significantly by the addition of the 3xFlag epitope tag. We
also were able to obtain Hdh
3xFlag140Q/3xFlag140Q homozy-
gotes from heterozygous intercrosses, but future studies
comparing both the behavior and neuropathology in
Hdh
140Q/140Q and Hdh
3xFlag140Q/3xFlag140Q mice are needed
to determine to what extent an N-terminal tag on mutant
htt could affect HD mouse model phenotypes.
Conclusion
The generation of new Hdh knock-in alleles expressing
N-terminal epitope-tagged htt with various polyQ
lengths has allowed us to begin to explore the inter-
action between normal and mutant htt, and to investi-
gate the consequence of expressing a normal htt with a
20Q stretch and human PRR in the CAG140 knock-in
model for HD. Substitution of the normal mouse exon 1
sequence in the wild-type Hdh allele with normal human
sequence can exacerbate some phenotypes in a heterozy-
gous CAG140 knock-in mouse model for HD, suggesting
that the length of the normal polyQ stretch and/or the
presence of a human PRR in normal huntingtin can
modulate HD mouse model pathogenesis. We hope that
these new Hdh knock-in alleles can be of use to the re-
search community.
Methods
All experiments with mice were carried out in accordance
with the ethical guidelines described in the “Guide for the
Care and Use of Laboratory Animals”, Institute of Laboratory
Animal Resources, National Research Council, 1996 edition.
All procedures were reviewed and approved by the Animal
Care and Use Committee of the University of Virginia.
Generation of mice
Partially complementary oligonucleotides containing se-
quence encoding an HA or 3xFlag N-terminal epitope tag,
an AlwNI restriction site at the 5´end, and an XmnIr e s t r i c -
tion site at the 3´end were annealed, repaired with the
Klenow fragment of DNA polymerase I, and then digested
with AlwNIa n dXmnI restriction enzymes to generate a
synthetic DNA fragment that was used to replace an endo-
genouse Hdh exon 1 AlwNI–XmnIf r a g m e n te n c o d i n gt h e
N-terminal amino acids of htt. Oligonucleotides used were,
HA-f: 5´-GTCTTCAGGGTCTGTCCCATCGGGCAGGA
AGCCG TCATGTACCCATACGACGTCCCAGACTACG
CT-3´, HA-r: 5´-CGACTCGAAAGCCTTCATCAGCTT
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GGTA-3´, Flag3x-f: 5´-GTCTTCAGGGTCTGTCCCATC
GGGCAGGAAGCCGTCATGGACTACAAAGACCATG
AGGGTGATTATAAAGATCATGACATCGACTACAAG
GACGACGATGACAAG-3´, Flag3x-r: 5´-CGACTCGA
AAGCCTTCATCAGCTTTTCCAGGGTTGCCTTGTCA
TCGTCGTCCTTGTAGTC-3´. For assembly of the
Hdh
3xFlag20Q gene targeting vector, An XmnI–KpnI
fragment containing human wild-type HTT sequence
was obtained by PCR from genomic DNA according to
the method described in [32]. This fragment contains the
human XmnI restriction site, a normal 20Q stretch, the
human proline-rich region (PRR), human sequence ex-
tending to the end of exon 1, a 100 bp intron 1 deletion
near the 5´-splice site of intron 1, and a KpnI restriction
site. For assembly of the Hdh
3xFlag140Q gene targeting
vector, the 3xFlag epitope tag AlwNI–XmnI restriction
fragment was used to replace the corresponding AlwNI–
XmnI fragment in our CAG140 targeting vector. Thus,
this vector also contains both the human PRR and intron
1 deletion. In contrast, insertion of the epitope tag se-
quences was the only modification made to the Hdh
HA7Q
and Hdh
3xFlag7Q gene targeting vectors. Following elec-
troporation of the targeting vectors into the W9.5 ES cell
line, targeted clones were identified by Southern blot
analysis as described [32]. Southern positive clones were
then screened for expression of epitope-tagged full-
length htt using anti-HA (HA.11, Covance) and anti-Flag
(FLAG M2, Sigma) antibodies. Mice were generated from
the targeted ES cell clones using standard procedures,
and germline transmission was obtained from at least
two independently-targeted ES cell clones for each con-
struct. All lines were backcrossed with C57BL/6J mice
for at least six generations.
Genotyping
For genotyping the Hdh
HA7Q and Hdh
3xFlag7Q alleles,
HDepi-1: 5´-GCGTAGTGCCAGTAGGCTCCAAG-3´and
HDepi-2: 5´-CTGAAACGACTTGAGCGACTCGAAAG-3
amplify a portion of the Hdh sequence flanking the epitope
tag insertion site between mouse htt amino acids 1 and 2.
A wild-type Hdh allele will generate a 112 bp PCR product,
while the Hdh
3xFlag7Q allele will generate a 178 bp product
due to the insertion of the 22 amino acid 3xFlag epitope
tag. The Hdh
HA7Q allele generates a 139 bp PCR product
due to the insertion of the nine amino acid HA epitope tag.
For genotyping the Hdh
3xFlag20Q and Hdh
3xFlag140Q alleles,
HDepi-1 and HuHDepi-2: 5´-GAAGGACTTGAGGGA
CTCGAAGG-3´are used. HuHDepi-2 is homologous to
the human sequence located 3´of the XmnIr e s t r i c t i o n
w i t h i ne x o n1o fb o t ht h eHdh
3xFlag20Q and Hdh
3xFlag140Q
alleles. Both the Hdh
3xFlag20Q and Hdh
3xFlag140Q alleles will
generate a 176 bp PCR product with this primer pair, while
no product will be generated from the wild-type Hdh allele.
Alternatively, the Hdh
3xFlag20Q and Hdh
3xFlag140Q alleles can
be genotyped by using 140for: 5´-CTGCACCGACCGT
GAGTCC-3´ and 140rev: 5´-GAAGGCACTGGAGTCGT
GAC-3´. These primers flank the 100 bp intron 1 deletion
that is present in the Hdh
3xFlag20Q, Hdh
3xFlag140Q,a n d
Hdh
140Q alleles, and will generate a 150 bp PCR product,
while the wild-type Hdh, Hdh
3xFlag7Q,a n dHdh
HA7Q alleles
lacking the intron 1 deletion generate a 235 bp product.
The CAG repeat lengths in the Hdh
3xFlag20Q (23Q),
Hdh
3xFlag140Q (136Q) alleles were determined by PCR se-
quencing (Laragen, Inc.) of genomic DNA isolated from tail
biopsies.
Co-immunoprecipitation
Whole brain tissue was dounce homogenized in extr-
action buffer {50 mM Tris–HCl pH 8.8, 100 mM NaCl,
5 mM MgCl2, 1 mM EDTA pH 8.0, 0.5% (v/v) NP40,
protease inhibitor cocktail (Thermo Scientific), with 5
mM NaF and 1 mM sodium vanadate} on ice, and then
centrifuged at 16,100×g for 10´at 4°C to obtain a crude
cytoplasmic supernatant fraction. Co-immunoprecipitation
was performed by incubating protein extracts with either
FLAG M2 antibody-agarose beads or by incubating anti-
body (FLAG M2 or 1C2) with the extract, followed by
capture of the antigen-antibody complex with Protein
G-agarose beads. In the first method, 0.5–1.0 mg of the
protein lysate was incubated by rotation o/n at 4°C with
12–20 μl FLAG M2 antibody-agarose beads (Sigma) that
were pre-washed three times with 0.5 ml extraction buffer
according to the manufacturer’s instructions. Following in-
cubation of the antibody-agarose beads with the extract,
the beads were pelleted by centrifugation at 8,200×g for 30
sec at 4°C, and the supernatant was carefully removed and
saved as the antibody non-bound fraction (NB). The beads
were then washed three times with 0.5 ml ice-cold extrac-
tion buffer. Antibody-bound protein was eluted with two
sequential incubations in 30 μl0 . 4m g / m l3 x F l a gp e p t i d e
(Sigma) dissolved in extraction buffer. Both elution frac-
tions were then combined as the antibody-bound (B) frac-
tion. NB- and B-samples were fractionated on 5% SDS-
PAGE and then transferred electrophoretically o/n at 30V
in 25 mM Tris base, 192 mM glycine, 10% methanol,
0.025% SDS to 0.45 μm PVDF membranes (Millipore).
In the second method, 500 μg cytoplasmic extract
was incubated o/n at 4°C with 5–6 μgF L A GM 2o r
1C2 antibody. 20 μl Protein-G agarose beads (Up-
state Biotechnology; washed once in extraction buf-
fer, blocked for 1 h at 4°C in 1% blocking powder
{Boehringer} dissolved in TBS, and then washed 3X
in extraction buffer prior to resuspending in the ori-
ginal volume of the same buffer), was then added to
the mixture of protein extract and antibody. This
mixture was then rotated for 3 hr at 4°C to bind the
antibody-antigen complexes to the beads. The beads were
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as the NB-fraction, and then the beads were washed as
described previously for the anti-FLAG M2-agarose beads.
The B-fraction was eluted from the beads by adding 50 μl
3× SDS-PAGE sample loading buffer to the beads, and in-
cubating for 5 min at 99°C in a heating block. The beads
were then pelleted, and the supernatant transferred to a
fresh tube. 5% of the NB-fraction and 50% of the B-
fraction were analyzed by SDS-PAGE and western blotting
as described above. Western blot membranes were
blocked in 5% milk in TBS-0.05% Tween 20 (TBST) prior
to incubation o/n at 4°C with either FLAG M2, (Sigma),
HA.11 (Covance), the expanded polyQ-specific monoclonal
antibody 1C2 (MAB1574, Millipore) or MAB2166 (Milli-
pore). Membranes were washed five times with TBST be-
fore incubation with secondary goat anti-mouse IgG-HRP
conjugated antibodies (Pierce) for 1 h at room temperature.
Following an additional five washes, the membranes were
incubated with West-Dura chemiluminescence substrate
(Pierce) and then exposed to film. For quantification of the
blots, exposures within the linear range of the film were
scanned, and then analyzed by Image J software (http://ima-
gej.nih.gov/ij/download.html). The percentage of 140Q-htt
co-immunoprecipitating with 3xFlag20Q-htt was deter-
mined by dividing the pixel intensity of the B-fraction
140Q-htt signal by the NB-fraction signal, and then adjust-
ing for the fraction of each sample loaded, and also for the
efficiency of 3xFlag20Q-htt immunoprecipitation as deter-
mined from the 2166 western blots (e.g. ~20% of
3xFlag20Q-htt was immunoprecipitated in the experi-
ment shown in Figure 5C, and the % of 140Q-htt
associating with 3xFlag20Q-htt would then be cor-
rected by a factor of 100/20).
Western blot analysis of formic acid-solubilized htt
aggregates
Brains were cut in half (sagittally), and each half brain
was dounce-homogenized in 2 ml extraction buffer on
ice, before centrifugation at 800×g for 15´ at 4°C to
obtain a crude nuclear pellet fraction. Formic acid-
solubilized nuclear htt aggregates were obtained follow-
ing the procedures of [39] and [40] with modifications.
The crude nuclear fraction was first resuspended in ex-
traction buffer, and then boiled 15 min in the presence
of SDS prior to sonication with a Fisher Scientific 550
probe sonicator (power level 5 for 20 sec with pulses of
0.6 sec on/0.4 sec off). Following sonication, the sample
was centrifuged at 16,100xg for 15´at RT, and the SDS-
insoluble pellet was resuspended in formic acid and
incubated for 1 h at 37°C at 350 rpm. The sample was
then dried in a speed-vac and resuspended in 1M Tris
base to neutralize residual formic acid. An equal volume
of 2X SDS-PAGE loading buffer was added, and then
one third of the sample was incubated 5 min at 97°C
prior to fractionation on 4%–15% gradient SDS-PAGE
(BioRad) and blotting onto 0.45 μm PVDF membrane.
Blots were probed with Flag (FLAG M2, Sigma) and
expanded polyQ-specific (1C2, Millipore) antibodies,
and imaged using a ChemiDoc XRS+ (BioRad) with
West-Dura chemiluminescence reagents (Pierce).
Filter trap assay for htt aggregation
Whole brains were dounce homogenized in extraction
buffer and centrifuged at 800×g for 15´at 4°C to obtain a
crude nuclear pellet fraction. Aliquots of this fraction
were treated for 60 minutes on ice with 0.1 mg/ml
DNAse I, SDS was then added to 2% final concentration,
and incubated 5 minutes at 99°C prior to spotting onto a
cellulose acetate/PVDF membrane sandwich. SDS-
resistant htt inclusions are trapped on the cellulose acet-
ate membrane while soluble 3xFlag7Q-htt and 140Q-htt
species are retained on the underlying PVDF membrane.
Htt inclusions were detected by western blotting with
the 1C2 and MAB5374 antibodies, while sequestered
3xFlag7Q-htt was detected with the FLAG M2 antibody.
Immunohistochemistry
Dissected brains were flash-frozen in isopentane on dry
ice, and then serially sectioned at 14 μm on a cryostat
(Bright Instrument Co.). Sections were either used imme-
diately or stored at −80°C until use. Sections were washed
briefly in PBS, fixed for 10 min in 4% paraformaldeyde in
0.1M phosphate buffer pH 7.4, and washed in PBS three
times before blocking with a 1:100 dilution of monovalent
Fab fragments (donkey anti-mouse IgG (H+L), Jackson
ImmunoResearch) in blocking buffer (5% donkey serum,
0.1% Triton X100 in PBS) for 1 h at RT, followed by three
washes in PBS, and then incubated o/n at 4°C with pri-
mary antibody diluted in blocking buffer. Primary anti-
bodies used were mouse monoclonal MW8 (1:70,
Developmental Studies Hybridoma Bank), mouse mono-
clonal MAB5375 (1:100, mEM48, Millipore), mouse
monoclonal FLAG M2 (1:100, Sigma), mouse monoclonal
HA.11 (1:100, Covance), and rabbit anti-GFAP (1:1000,
AB5804, Millipore). Following incubation with the pri-
mary antibody, sections were washed three times in PBS,
and then incubated with secondary antibody (Cy3- or
FITC-conjugated donkey anti-mouse or donkey anti-
rabbit-IgG, Jackson ImmunoResearch) together with the
fluorescent DNA stain To-Pro-3 iodide (Invitrogen) in
blocking buffer for 1 h at RT. Sections were then washed
with PBS before treating with Autofluorescence Elimin-
ator Reagent (Millipore) following the manufacturer’s
instructions. Sections were then mounted withVectashield
(Vector Laboratory) and examined using either an Olym-
pus BX51 microscope equipped with a MagnaFire CCD
camera or a Nikon C1 confocal system.
Zheng et al. Molecular Brain 2012, 5:28 Page 17 of 19
http://www.molecularbrain.com/content/5/1/28Immunohistochemical detection of htt aggregates
following formic acid treatment
The method described in [41] was adapted for fresh fro-
zen sections. Sections were washed briefly in PBS, and
fixed in 4% paraformaldehyde in 0.1M PB for 15 min at
RT. Sections were then washed twice in PBS, once with
water (10 min each), and then treated with formic acid
(Sigma) three times for 10 min each. The sections were
rinsed three times in water and washed twice for 10 min
each in PBS, followed by 30 min incubation in 1% so-
dium borohydride (w/v) in PBS, and then washed three
times for 10 min each in PBS prior to immunohisto-
chemical staining using the monoclonal 1C2 antibody
(1:100, Millipore).
Quantification of htt aggregates using the MW8 antibody
Tissue sections were imaged with a 60X objective using
a Nikon C1 confocal microscope, and the number of
MW8
+ huntingtin aggregates was counted blind to
genotype from sagittal sections through the striatum
(8 images from sections separated by 280 μm through
the striatum, n=4 mice of each genotype) using ImagePro
4.5 software (Media Cybernetics). Neuropil and nuclear
inclusions were counted separately. To determine the
mean size of inclusions, the total pixel area was divided by
the number of inclusions in each imaging field.
Lipofuscin analysis. Imaging and quantification of lipo-
fuscin was performed as described in [46].
Statistical analyses
χ
2 analyses of the genotypes were performed using Sig-
maStat (Systat software). Student’s t-test was used to
evaluate significance in the quantification of aggregate
numbers, aggregate mean size, and co-localization of
MW8 and 3xFlag epitopes in htt aggregates.
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